CompaniesByCap
ALT
Altimmune, Inc. (ALT)
NASDAQ · Healthcare

Altimmune, Inc. Cash Flow 2010–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2012Dec 2011Dec 2010
Operating Activities
Operating Cash Flow-67.5M-79.8M-75.8M-62.6M-78.2M-34.3M-9.6M-9.4M-20.2M-2.3M-7.8M-14.9M
Depreciation & Amort.-205,000551,301428,878387,321303,916461,0731.0M
Investing Activities
Capital Expenditure11,00047,000126,00012.1M203,9571,227975,407112,44171,439374,581
Free Cash Flow-67.5M-75.9M-62.7M-90.4M-34.5M-9.6M-10.4M-20.3M-7.9M-15.2M
Financing Activities
Dividends Paid
Stock Buybacks

Altimmune, Inc. Cash Flow — FAQ

Altimmune, Inc. (ALT) cash flow over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ALT's cash flow history?

The chart and table above show Altimmune, Inc.'s cash flow by year and by quarter, including the growth rate.